Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend

Award-Winning Patented Cannabinoid Release Gum, CanChew(R), Donated in Support of U.S. Service Members at July 4th Weekend Event

New York, New York, UNITED STATES

NEW YORK, July 2, 2015 (GLOBE NEWSWIRE) -- When signing the Clay Hunt Suicide Prevention for American Veterans Act, President Obama called on Americans to, "Reach out and do more with and for our veterans."

A photo accompanying this release is available at

AXIM Biotechnologies, Inc. (OTC:AXIM) is honoring that request by supporting Adopt-A-Soldier Platoon, Inc. with a generous donation of CanChew® an award-winning, patented cannabidiol chewing gum. The product donation will be distributed by Adopt-A-Soldier Platoon, Inc. at the private, invitation-only Warfighter Independence Weekend July 3rd – 4th. Perhaps the first of its kind event hosted "by Warfighters for Warfighters," organizers are working to create a network of caring Veterans who can help those with suicidal ideations.

"Our Veterans need someone – not only someone who can relate – but someone who has been through what these Veterans have been through," states Alan Krutchkoff, President of Adopt-A-Soldier Platoon, Inc. "Most do not want to talk to psychologists or psychiatrists unless they have been in the military; they prefer to talk to their own. The Warfighters Independence Weekend strives to make that a reality. Through this event, we intend to create new deeper bonds with those invited and in attendance. Our hope is to save one or more lives in the process. We are thankful to AXIM for their continuous support of our heroes."

Adopt-A-Soldier Platoon, Inc. is focused on reducing the effects of post-traumatic stress (PTS) and traumatic brain injury (TBI), as well as helping create a network of Warfighters for Warfighters to reduce the suicide rate. The all-volunteer charity gives 100% of all donations to its Operation Combat Care program to wounded Soldiers, Sailors, Marines and Airmen and those having a difficult time transitioning from combat to civilian life. Details about the event can be found on the organization's website.

CanChew® is a unique hemp chewing gum that is distinctly different than any other brands of gum on the market. Features listed on the CanChew® website include:

  • Non-habit forming
  • No prescription needed
  • Available in all 50 states
  • Great-tasting mint gum has no artificial sweeteners or preservatives
  • Non-GMO, gluten free, vegan and kosher

Featured in Healthy Living Magazine, CanChew® was also recognized by the HealthyLivinGFoundation and honored with its Triple Leaf Award.

AXIM Biotech's core belief and mission is developing cannabinoid-based solutions to address current conditions with no known effective treatment including: Parkinson's disease, Alzheimer's disease / dementia, ADHD (attention deficit hyperactivity disorder), PTSD, autism, MS, spasticity, pain, RLS (restless leg syndrome), glaucoma, IBD, IBS and Crohn's disease.

AXIM Biotech's Chief Executive Officer, George Anastassov, DDS, MD, MBA, is a guest speaker at the Cannabis Conference Chicago. There, he will present information on cannabinoid delivery methods to the public, medical cannabis patients and healthcare professionals July 23rd – 25th at Navy Pier.

AXIM Biotech has been featured by media outlets including: FOX Business,, MJ Freeway, Chemical & Engineering News, Dental Tribune, Pharmaceutical Commerce, Dental Products Report and MJI News. For more information, visit AXIM Biotech's website.

To arrange for media interviews, contact Andrew Hard, Public Relations Spokesperson, at or call 858-380-5478.

About AXIM:

AXIM Biotechnologies, Inc. (OTC:AXIM) is an innovative biotechnology Company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products where we prioritize the well-being of our customers while embracing a solid fiscal strategy. For more information, visit the Company website at


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Axim Biotechnologies, Inc. to be materially different from the statements made herein.


AXIM Biotechnologies does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell, and distribute hemp-based products.

The photo is also available at Newscom,, and via AP PhotoExpress.


Contact Data